Bayesian local exchangeability design for phase II basket trials

被引:6
作者
Liu, Yilin [1 ]
Kane, Michael [1 ]
Esserman, Denise [1 ]
Blaha, Ondrej [1 ]
Zelterman, Daniel [1 ]
Wei, Wei [1 ]
机构
[1] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
adaptive design; Bayesian analysis; clustering; master protocol; oncology; MULTIPLE TUMOR TYPES; STATISTICAL DESIGN; MASTER PROTOCOLS; CLINICAL-TRIALS; INHIBITION; BRAF;
D O I
10.1002/sim.9514
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We propose an information borrowing strategy for the design and monitoring of phase II basket trials based on the local multisource exchangeability assumption between baskets (disease types). In our proposed local-MEM framework, information borrowing is only allowed to occur locally, that is, among baskets with similar response rate and the amount of information borrowing is determined by the level of similarity in response rate, whereas baskets not considered similar are not allowed to share information. We construct a two-stage design for phase II basket trials using the proposed strategy. The proposed method is compared to competing Bayesian methods and Simon's two-stage design in a variety of simulation scenarios. We demonstrate the proposed method is able to maintain the family-wise type I error rate at a reasonable level and has desirable basket-wise power compared to Simon's two-stage design. In addition, our method is computationally efficient compared to existing Bayesian methods in that the posterior profiles of interest can be derived explicitly without the need for sampling algorithms. R scripts to implement the proposed method are available at .
引用
收藏
页码:4367 / 4384
页数:18
相关论文
共 30 条
  • [11] Kaizer Alexander M, 2019, JCO Precis Oncol, V3, P1, DOI 10.1200/PO.19.00194
  • [12] Bayesian hierarchical modeling based on multisource exchangeability
    Kaizer, Alexander M.
    Koopmeiners, Joseph S.
    Hobbs, Brian P.
    [J]. BIOSTATISTICS, 2018, 19 (02) : 169 - 184
  • [13] Kane MJ., 2021, R J, V12, P342, DOI [10.32614/RJ-2021-020, DOI 10.32614/RJ-2021-020]
  • [14] Kane MJ., 2019, ARXIV PREPRINT ARXIV
  • [15] Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS)
    Kang, Daniel
    Coffey, Christopher
    Smith, Brian
    Yuan, Ying
    Shi, Qian
    Yin, Jun
    [J]. STATISTICS IN MEDICINE, 2021, 40 (12) : 2893 - 2921
  • [16] Increasing the efficiency of oncology basket trials using a Bayesian approach
    Liu, Rong
    Liu, Zheyu
    Ghadessi, Mercedeh
    Vonk, Richardus
    [J]. CONTEMPORARY CLINICAL TRIALS, 2017, 63 : 67 - 72
  • [17] NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era
    McNeil, Caroline
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
  • [18] The National Lung Matrix Trial of personalized therapy in lung cancer
    Middleton, Gary
    Fletcher, Peter
    Popat, Sanjay
    Savage, Joshua
    Summers, Yvonne
    Greystoke, Alastair
    Gilligan, David
    Cave, Judith
    O'Rourke, Noelle
    Brewster, Alison
    Toy, Elizabeth
    Spicer, James
    Jain, Pooja
    Dangoor, Adam
    Mackean, Melanie
    Forster, Martin
    Farley, Amanda
    Wherton, Dee
    Mehmi, Manita
    Sharpe, Rowena
    Mills, Tara C.
    Cerone, Maria Antonietta
    Yap, Timothy A.
    Watkins, Thomas B. K.
    Lim, Emilia
    Swanton, Charles
    Billingham, Lucinda
    [J]. NATURE, 2020, 583 (7818) : 807 - 812
  • [19] Robust exchangeability designs for early phase clinical trials with multiple strata
    Neuenschwander, Beat
    Wandel, Simon
    Roychoudhury, Satrajit
    Bailey, Stuart
    [J]. PHARMACEUTICAL STATISTICS, 2016, 15 (02) : 123 - 134
  • [20] Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
    Prahallad, Anirudh
    Sun, Chong
    Huang, Sidong
    Di Nicolantonio, Federica
    Salazar, Ramon
    Zecchin, Davide
    Beijersbergen, Roderick L.
    Bardelli, Alberto
    Bernards, Rene
    [J]. NATURE, 2012, 483 (7387) : 100 - U146